# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:MED) from Neutral to Underperform and lowers the price tar...
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $40 to...